Who owns Damora Therapeutics, Inc., from the filings themselves: stakes over 5% (Schedule 13D/G), the institutional managers reporting the stock each quarter (13F), and the funds holding it (N-PORT).
Investors crossing 5% ownership must disclose it. Schedule 13G filers certify the stake is passive; Schedule 13D is the general form for everyone else — founders, strategic holders, and activists alike. Each entry is the holder's most recent disclosure. Coverage begins with SEC's structured filings from December 18, 2024; a holder appears once they file or amend after that date.
Jain Global LLC: 0.0% · 0 shares — Jain Holdings LLC: 0.0% · 0 shares — Robert Jain: 0.0% · 0 shares
9 more 5% stakes behind a free account
See every investor who has disclosed crossing 5% of Damora Therapeutics, Inc..
Sign up freeEvery institutional manager whose latest 13F reports this stock, largest position first. "% of their portfolio" is the weight inside that manager's own book — how much conviction the position represents; "% of company" is how much of Damora Therapeutics, Inc. they hold. Together these 119 managers report 110.48% of shares outstanding.
| Investor | Position value | Shares | % of their portfolio | % of company | As of |
|---|---|---|---|---|---|
| FMR LLC | $240M | 9,232,979 | 0.01% | 14.96% | June 30, 2026 |
| Fairmount Funds Management LLC | $227M | 8,713,000 | 14.98% | 14.11% | June 30, 2026 |
117 more institutional holders behind a free account
See every manager reporting Damora Therapeutics, Inc., how much of the company they hold, and how big the position is inside their own portfolio.
Sign up freeFunds disclosing this stock in their monthly N-PORT portfolio, with the position's share of the fund's net assets. Together these 59 funds hold 14.26% of shares outstanding — counted inside the manager totals above, not on top of them, since a fund's shares also appear in its manager's 13F.
| Fund | Position value | % of net assets | % of company | As of |
|---|---|---|---|---|
| Fidelity Growth Company Fund | $52M | 0.06% | 2.85% | February 28, 2026 |
| Fidelity Small Cap Growth Fund | $21.4M | 0.25% | 1.35% | April 30, 2026 |
57 more funds behind a free account
See every fund holding Damora Therapeutics, Inc. and what share of its net assets the position represents.
Sign up freeLoading...
